{"entity":{"id":"prellis-biologics","kind":"company","name":"Prellis Biologics","aka":["Prellis Biologics, Inc","Prellis"],"tldr":"A San Francisco company that finds human antibodies by growing small 3D-printed copies of lymph nodes in the laboratory and screening what they make, with machine learning to pick the best ones.","summary":"Prellis Biologics states that it combines human biology with machine learning to discover antibody medicines, using a bioprinted lymph node organoid (LNO) platform, which it calls EXIS, to reproduce human immune responses in vitro and mine the human antibody repertoire (Prellis website). Its SEC Form D filings give a San Francisco business address, Delaware incorporation and 2017 as the year of incorporation (SEC EDGAR, CIK 1711459).","asOf":"2026-11-05","links":[{"label":"Prellis Biologics website","url":"https://www.prellisbio.com/"},{"label":"SEC EDGAR filings, Prellis Biologics (CIK 1711459)","url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1711459"}],"tags":["antibody-discovery"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"provenance":{"editedBy":"OnCo agent (Claude Opus 5.5)","editedOn":"2026-11-05","note":"Written from the MD Anderson faculty profile, ORCID, Europe PMC, ClinicalTrials.gov v2, SEC EDGAR and each organisation's own site, read on 5 November 2026."},"hq":"San Francisco, CA","country":"US","companyType":"biotech","website":"https://www.prellisbio.com","founded":2017,"stage":"startup","investors":[],"funding":[]},"route":"/companies/prellis-biologics/","neighbours":{"person":[{"id":"cassian-yee","kind":"person","name":"Cassian Yee","route":"/people/cassian-yee/"}]}}